Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia
Open Access
- 1 October 2014
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Pediatric Hematology/Oncology
- Vol. 36 (7), 503-517
- https://doi.org/10.1097/mph.0000000000000206
Abstract
Supplemental Digital Content is available in the text.Keywords
This publication has 160 references indexed in Scilit:
- Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALLNature Medicine, 2013
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 UpdateClinical Pharmacology & Therapeutics, 2013
- Liquid chromatography–tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standardJournal of Chromatography B, 2012
- Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemiaLeukemia, 2011
- Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: A Children's Oncology Group ReportLeukemia, 2009
- Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic LeukemiaClinical Pharmacology & Therapeutics, 2008
- Cytotoxic Mechanism of 6-Thioguanine: hMutSα, the Human Mismatch Binding Heterodimer, Binds to DNA Containing S6-MethylthioguanineBiochemistry, 1997
- Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemiaThe Journal of Pediatrics, 1990
- Methotrexate bioavailability after oral and intramuscular administration in childrenThe Journal of Pediatrics, 1987
- Variable Bioavailability of Oral MercaptopurineNew England Journal of Medicine, 1983